Tanaka, Masahiko et al "A 24-Week, Phase III, Double-Blind, Parallel-Group Study of Edaravone (MCI-186) for Treatment of Amyotrophic Lateral Sclerosis (ALS) (P3.189)." Neurology 86.16 Supplement (2016): P3.189. Web. 29 Sept2022.